SCHEMBL3201336

SCHEMBL3201336

O=C1NC(=S)c2cc3ccccc3n21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 3/20 0.44
NOTUM Q6P988 1/20 0.42
ALDH1A1 P00352 4/20 0.38
TSHR P16473 1/20 0.38
KMT2A Q03164 2/20 0.37
PRKD3 O94806 1/20 0.35
PRKCG P05129 1/20 0.35
PRKCB P05771 1/20 0.35
PRKCA P17252 1/20 0.35
PRKACA P17612 1/20 0.35
PRKACG P22612 1/20 0.35
PRKACB P22694 1/20 0.35
PRKCH P24723 1/20 0.35
PRKCI P41743 1/20 0.35
PRKCE Q02156 1/20 0.35
PRKCQ Q04759 1/20 0.35
PRKCZ Q05513 1/20 0.35
PRKCD Q05655 1/20 0.35
PRKD1 Q15139 1/20 0.35
DAO P14920 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3201330 0.77 PIM1 (0.67) PIM1NOTUMALDH1A1TSHRKMT2A
SCHEMBL3086867 0.70 KMT2A (0.43) PIM1NOTUMALDH1A1TSHRKMT2A
SCHEMBL3086865 0.69 KMT2A (0.42) PIM1NOTUMALDH1A1TSHRKMT2A
SCHEMBL31717960 0.67 RAB9A (0.47) NOTUMALDH1A1TSHRKMT2ADAO
SCHEMBL16179948 0.67 RAB9A (0.47) NOTUMALDH1A1TSHRKMT2ADAO
SCHEMBL10763517 0.65 KDM4E (0.38) TSHRKMT2AMAPTKDM4EBRD4
SCHEMBL29929810 0.64 MAPT (0.43) NOTUMALDH1A1TSHRKMT2AMAPT
SCHEMBL143400 0.64 MAPT (0.43) NOTUMALDH1A1TSHRKMT2AMAPT
SCHEMBL5917428 0.63 NOTUM (0.41) NOTUMALDH1A1TSHRKMT2ADAO
SCHEMBL6427867 0.63 KMT2A (0.47) NOTUMALDH1A1TSHRKMT2ADAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7795255-B2 Rigidified compounds for modulating heparanase activity INSIGHT BIOPHARMACEUTICALS LTD. (IL) 2010-09-14 US disclosed
US-20080039456-A1 Rigidified Compounds for Modulating Heparanase Activity INSIGHT BIOPHARMACEUTICALS LTD. (IL) 2008-02-14 US disclosed
EP-1846383-A2 RIGIDIFIED COMPOUNDS FOR MODULATING HEPARANASE ACTIVITY Insight Biopharmaceuticals Ltd. (IL) 2007-10-24 EP disclosed
WO-2006072953-A2 RIGIDIFIED COMPOUNDS FOR MODULATING HEPARANASE ACTIVITY INSIGHT BIOPHARMACEUTICALS LTD. (IL) 2006-07-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080039456-A1 Rigidified Compounds for Modulating Heparanase Activity HPSE, HEXA, GAA PIM1 3637/4885NOTUM 1211/4885ALDH1A1 2428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.